AAPL341.07+5.15 (+1.53%) ▲|ABBV264.34-0.78 (-0.29%) ▼|ABT101.29+0.22 (+0.22%) ▲|ACN176.11-1.30 (-0.73%) ▼|ADBE235.47-3.46 (-1.45%) ▼|AMAT485.00+10.75 (+2.27%) ▲|AMD630.63+1.37 (+0.22%) ▲|AMGN414.61+8.57 (+2.11%) ▲|AMT169.03+1.77 (+1.06%) ▲|AMZN249.67+0.29 (+0.12%) ▲|AVGO352.81+2.45 (+0.70%) ▲|AXP308.89+3.23 (+1.06%) ▲|BA198.07+1.27 (+0.65%) ▲|BAC56.70+0.67 (+1.20%) ▲|BKNG163.95+6.54 (+4.15%) ▲|BLK1,086.31+12.86 (+1.20%) ▲|BMY62.86+1.36 (+2.21%) ▲|BNY150.15-0.04 (-0.03%) ▼|BRK-B505.48+0.30 (+0.06%) ▲|C134.28+2.18 (+1.65%) ▲|CAT821.58+16.33 (+2.03%) ▲|CL86.06+0.74 (+0.87%) ▲|CMCSA21.91-0.22 (-0.99%) ▼|COF200.20+3.59 (+1.83%) ▲|COP127.30-2.04 (-1.58%) ▼|COST922.77+26.29 (+2.93%) ▲|CRM234.02-4.20 (-1.76%) ▼|CSCO106.70-0.27 (-0.25%) ▼|CVS89.13+4.08 (+4.80%) ▲|CVX204.45-1.20 (-0.58%) ▼|DE690.46-4.48 (-0.64%) ▼|DHR224.49+0.72 (+0.32%) ▲|DIS106.15+0.59 (+0.56%) ▲|DUK113.35+0.12 (+0.11%) ▲|EMR158.23+2.09 (+1.34%) ▲|FDX285.85+6.31 (+2.26%) ▲|GD336.72+0.43 (+0.13%) ▲|GE327.09+7.31 (+2.29%) ▲|GEV957.63+2.59 (+0.27%) ▲|GILD150.93+1.24 (+0.83%) ▲|GM82.63+2.06 (+2.56%) ▲|GOOG341.08+2.07 (+0.61%) ▲|GOOGL343.92+1.56 (+0.46%) ▲|GS935.45+12.16 (+1.32%) ▲|HD293.20+1.02 (+0.35%) ▲|HON212.55+0.76 (+0.36%) ▲|IBM225.51-1.55 (-0.68%) ▼|INTC123.00-4.39 (-3.45%) ▼|INTU275.79-1.34 (-0.48%) ▼|ISRG405.18+5.66 (+1.42%) ▲|JNJ271.22+0.54 (+0.20%) ▲|JPM343.06+4.50 (+1.33%) ▲|KO87.81-0.29 (-0.33%) ▼|LIN469.89+1.75 (+0.37%) ▲|LLY1,183.46+1.57 (+0.13%) ▲|LMT519.56-4.14 (-0.79%) ▼|LOW189.28+0.79 (+0.42%) ▲|LRCX315.21+8.05 (+2.62%) ▲|MA567.65+1.57 (+0.28%) ▲|MCD236.50-0.52 (-0.22%) ▼|MDLZ60.25-0.61 (-1.00%) ▼|MDT88.64+0.85 (+0.97%) ▲|META751.66-25.93 (-3.33%) ▼|MMM169.55+2.03 (+1.21%) ▲|MO68.82-0.06 (-0.09%) ▼|MRK148.78+0.80 (+0.54%) ▲|MS196.31-0.01 (-0.01%) ▼|MSFT516.17+18.24 (+3.66%) ▲|MU1,082.28+1.75 (+0.16%) ▲|NEE76.08+0.46 (+0.61%) ▲|NFLX71.15-0.58 (-0.80%) ▼|NKE35.75-0.24 (-0.67%) ▼|NOW135.62-2.16 (-1.57%) ▼|NVDA225.07+0.49 (+0.22%) ▲|ORCL137.10-2.44 (-1.75%) ▼|PEP128.63+0.48 (+0.37%) ▲|PFE28.67+0.26 (+0.92%) ▲|PG146.23+0.55 (+0.38%) ▲|PLTR189.67-2.92 (-1.52%) ▼|PM190.48-1.02 (-0.53%) ▼|QCOM201.97+7.71 (+3.97%) ▲|RTX189.40+0.79 (+0.42%) ▲|SBUX94.86+1.21 (+1.29%) ▲|SCHW99.03-0.46 (-0.46%) ▼|SO82.88-0.01 (-0.01%) ▼|SPG204.82+0.12 (+0.06%) ▲|T25.38-0.07 (-0.28%) ▼|TMO675.00-3.39 (-0.50%) ▼|TMUS165.43+0.08 (+0.05%) ▲|TSLA372.11-5.83 (-1.54%) ▼|TXN278.07+7.42 (+2.74%) ▲|UBER69.62+0.40 (+0.58%) ▲|UNH376.59+1.58 (+0.42%) ▲|UNP273.79-0.28 (-0.10%) ▼|UPS93.96+1.91 (+2.08%) ▲|USB59.33+0.93 (+1.59%) ▲|V367.38-0.60 (-0.16%) ▼|VZ47.08-0.24 (-0.51%) ▼|WFC82.97+0.79 (+0.96%) ▲|WMT107.98+0.39 (+0.36%) ▲|XOM160.59-1.55 (-0.96%) ▼|AAPL341.07+5.15 (+1.53%) ▲|ABBV264.34-0.78 (-0.29%) ▼|ABT101.29+0.22 (+0.22%) ▲|ACN176.11-1.30 (-0.73%) ▼|ADBE235.47-3.46 (-1.45%) ▼|AMAT485.00+10.75 (+2.27%) ▲|AMD630.63+1.37 (+0.22%) ▲|AMGN414.61+8.57 (+2.11%) ▲|AMT169.03+1.77 (+1.06%) ▲|AMZN249.67+0.29 (+0.12%) ▲|AVGO352.81+2.45 (+0.70%) ▲|AXP308.89+3.23 (+1.06%) ▲|BA198.07+1.27 (+0.65%) ▲|BAC56.70+0.67 (+1.20%) ▲|BKNG163.95+6.54 (+4.15%) ▲|BLK1,086.31+12.86 (+1.20%) ▲|BMY62.86+1.36 (+2.21%) ▲|BNY150.15-0.04 (-0.03%) ▼|BRK-B505.48+0.30 (+0.06%) ▲|C134.28+2.18 (+1.65%) ▲|CAT821.58+16.33 (+2.03%) ▲|CL86.06+0.74 (+0.87%) ▲|CMCSA21.91-0.22 (-0.99%) ▼|COF200.20+3.59 (+1.83%) ▲|COP127.30-2.04 (-1.58%) ▼|COST922.77+26.29 (+2.93%) ▲|CRM234.02-4.20 (-1.76%) ▼|CSCO106.70-0.27 (-0.25%) ▼|CVS89.13+4.08 (+4.80%) ▲|CVX204.45-1.20 (-0.58%) ▼|DE690.46-4.48 (-0.64%) ▼|DHR224.49+0.72 (+0.32%) ▲|DIS106.15+0.59 (+0.56%) ▲|DUK113.35+0.12 (+0.11%) ▲|EMR158.23+2.09 (+1.34%) ▲|FDX285.85+6.31 (+2.26%) ▲|GD336.72+0.43 (+0.13%) ▲|GE327.09+7.31 (+2.29%) ▲|GEV957.63+2.59 (+0.27%) ▲|GILD150.93+1.24 (+0.83%) ▲|GM82.63+2.06 (+2.56%) ▲|GOOG341.08+2.07 (+0.61%) ▲|GOOGL343.92+1.56 (+0.46%) ▲|GS935.45+12.16 (+1.32%) ▲|HD293.20+1.02 (+0.35%) ▲|HON212.55+0.76 (+0.36%) ▲|IBM225.51-1.55 (-0.68%) ▼|INTC123.00-4.39 (-3.45%) ▼|INTU275.79-1.34 (-0.48%) ▼|ISRG405.18+5.66 (+1.42%) ▲|JNJ271.22+0.54 (+0.20%) ▲|JPM343.06+4.50 (+1.33%) ▲|KO87.81-0.29 (-0.33%) ▼|LIN469.89+1.75 (+0.37%) ▲|LLY1,183.46+1.57 (+0.13%) ▲|LMT519.56-4.14 (-0.79%) ▼|LOW189.28+0.79 (+0.42%) ▲|LRCX315.21+8.05 (+2.62%) ▲|MA567.65+1.57 (+0.28%) ▲|MCD236.50-0.52 (-0.22%) ▼|MDLZ60.25-0.61 (-1.00%) ▼|MDT88.64+0.85 (+0.97%) ▲|META751.66-25.93 (-3.33%) ▼|MMM169.55+2.03 (+1.21%) ▲|MO68.82-0.06 (-0.09%) ▼|MRK148.78+0.80 (+0.54%) ▲|MS196.31-0.01 (-0.01%) ▼|MSFT516.17+18.24 (+3.66%) ▲|MU1,082.28+1.75 (+0.16%) ▲|NEE76.08+0.46 (+0.61%) ▲|NFLX71.15-0.58 (-0.80%) ▼|NKE35.75-0.24 (-0.67%) ▼|NOW135.62-2.16 (-1.57%) ▼|NVDA225.07+0.49 (+0.22%) ▲|ORCL137.10-2.44 (-1.75%) ▼|PEP128.63+0.48 (+0.37%) ▲|PFE28.67+0.26 (+0.92%) ▲|PG146.23+0.55 (+0.38%) ▲|PLTR189.67-2.92 (-1.52%) ▼|PM190.48-1.02 (-0.53%) ▼|QCOM201.97+7.71 (+3.97%) ▲|RTX189.40+0.79 (+0.42%) ▲|SBUX94.86+1.21 (+1.29%) ▲|SCHW99.03-0.46 (-0.46%) ▼|SO82.88-0.01 (-0.01%) ▼|SPG204.82+0.12 (+0.06%) ▲|T25.38-0.07 (-0.28%) ▼|TMO675.00-3.39 (-0.50%) ▼|TMUS165.43+0.08 (+0.05%) ▲|TSLA372.11-5.83 (-1.54%) ▼|TXN278.07+7.42 (+2.74%) ▲|UBER69.62+0.40 (+0.58%) ▲|UNH376.59+1.58 (+0.42%) ▲|UNP273.79-0.28 (-0.10%) ▼|UPS93.96+1.91 (+2.08%) ▲|USB59.33+0.93 (+1.59%) ▲|V367.38-0.60 (-0.16%) ▼|VZ47.08-0.24 (-0.51%) ▼|WFC82.97+0.79 (+0.96%) ▲|WMT107.98+0.39 (+0.36%) ▲|XOM160.59-1.55 (-0.96%) ▼|
15.6 C
New York
Sunday, September 27, 2026

Tag: information

newssourceFORcompanyinformationcontent1releasesmarket

Carbon Revolution Secures Final Release of $5 Million from OIC and Final $0.4 Million Reserve Release from Existing Lenders

GEELONG, Australia, July 25, 2025 (GLOBE NEWSWIRE) -- Carbon Revolution plc (Nasdaq: CREV) (the “Company”), a Tier 1 OEM supplier and the leading global manufacturer of lightweight advanced technology automotive carbon fiber wheels, today announced that Orion Infrastructure Capital ("OIC") has released US$5 million of the US$25 million facility announced on December 23, 2024. As a result of this release, the full US$25 million facility has now been released. Concurrent with this US$5 million tranche, lenders under the US$60 million PIUS loan entered into in May 2023 (“Existing Noteholders”) have also released the final US$400,000 of existing loan reserves, taking reserves released to US$2 million. In connection with this funding tranche, the Company will issue to OIC and Existing Noteholders, penny warrants to purchase an aggregate number of shares equal to 5.0% of the Company’s shares outstanding.

Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025

Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025

Celcuity to Announce Topline Results for the PIK3CA Wild-Type Cohort from Phase 3 VIKTORIA-1 Trial in HR+/HER2- Advanced Breast Cancer

MINNEAPOLIS, July 25, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the Company will hold a conference call and webcast on Monday, July 28, 2025 at 8:00 AM ET to disclose the topline results of the PIK3CA Wild-Type Cohort from the Phase 3 VIKTORIA-1 trial.

Epic fantasy strategy game, Elemental returns as Elemental: Reforged

Stardock reforges and integrates War of Magic, Fallen Enchantress and Sorcerer King to fulfill the original vision for Elemental PLYMOUTH, Mich., July 25, 2025 /PRNewswire/ --...

IRADIMED CORPORATION to Hold Second Quarter of 2025 Financial Results Conference Call on August 1, 2025

ORLANDO, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2025 second quarter financial results before the market opens on Friday, August 1, 2025. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions.

Recognify Life Sciences Provides Update on Phase 2b Trial of Inidascamine in Patients with Cognitive Impairment Associated with Schizophrenia

SOUTH SAN FRANCISCO, July 25, 2025 (GLOBE NEWSWIRE) -- Recognify Life Sciences, a clinical-stage biotech company focused on developing treatments for cognitive impairment, today announced that its randomized, double-blind, placebo-controlled Phase 2b clinical trial evaluating inidascamine (formerly RL-007) in patients with cognitive impairment associated with schizophrenia (CIAS) did not meet its primary endpoint.

NurExone Biologic Finalist in Falling Walls Venture 2025 Global Platform Showcasing The World’s Most Promising Science-Based Start-Ups

Company to compete for “Science Breakthrough of the Year” at Europe’s leading deep-tech summit in Berlin, Germany this November 
Company to compete for “Science Breakthrough of the Year” at Europe’s leading deep-tech summit in Berlin, Germany this November

TSA seeks private sector solutions to enhance airport security and passenger experience

Submissions for Request for Information now open on SAM.gov WASHINGTON, July 25, 2025 /PRNewswire/ -- The Transportation Security Administration (TSA) recently issued a Request for...

CAPR Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Capricor Therapeutics, Inc. Securities Class Action

Robbins LLP is Investigating Allegations that Capricorn Therapeutics, Inc. (CAPR) Misled Investors Regarding the Viability of Deramiocel

Everlight Solar Named Milwaukee’s Top Choice Winner

MILWAUKEE, July 24, 2025 /PRNewswire/ -- Everlight Solar is honored to announce its recognition as a Milwaukee Top Choice winner for 2025. This community-powered...

#BackToSchool Ready: YITAHOME’s Must-Have Collection

LONDON, July 25, 2025 (GLOBE NEWSWIRE) -- YITAHOME is excited to kick off its #BacktoSchool campaign, unveiling a fresh collection of smart, stylish, and space-saving furniture designed to meet the unique needs of students and families gearing up for the upcoming academic year. Available now on Amazon, this thoughtfully curated collection is all about maximizing space, reducing clutter, and keeping everything organized—without compromising on design or style. Whether it's for a dorm room, apartment, or home office, YITAHOME has the perfect solution for every student’s space.

Spear AI Secures Seed Funding from Scare the Bear Capital and Cortical Ventures to Accelerate Maritime AI Solutions and Expand Technical Services

WASHINGTON, July 25, 2025 /PRNewswire/ -- Spear AI, a leading developer of maritime artificial intelligence solutions, today announced the successful completion of its seed funding...

KPN completes € 250m share buyback

Today, KPN announces the completion of its € 250m share buyback, which commenced on 25 February 2025 and was completed on 25 July 2025. In total, KPN has repurchased 62,465,117 ordinary shares at an average price of € 4.00 per share.

Menovelle ‘Coffee Hack’ Fixes Hot Flashes, Belly Weight Gain & Mood Swings, Research Suggests

A Natural Supplement Trend in 2025, Menovelle Helps Women Support Hormonal Balance and Metabolic Energy Without Hormone Therapy or Stimulants 
A Natural Supplement Trend in 2025, Menovelle Helps Women Support Hormonal Balance and Metabolic Energy Without Hormone Therapy or Stimulants

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsInformation

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers